Veterinary Medicine Information website

ELETTROLITICA REIDRATANTE III S.A.L.F. Soluzione isotonica per infusione endovenosa per bovini, equini, cani e gatti

Authorised
  • Sodium acetate
  • Calcium chloride dihydrate
  • Magnesium chloride hexahydrate
  • Potassium chloride
  • Sodium chloride
  • Sodium citrate dihydrate
Download as PDF

Product identification

Medicine name:
ELETTROLITICA REIDRATANTE III S.A.L.F. Soluzione isotonica per infusione endovenosa per bovini, equini, cani e gatti
Active substance:
  • Sodium acetate
  • Calcium chloride dihydrate
  • Magnesium chloride hexahydrate
  • Potassium chloride
  • Sodium chloride
  • Sodium citrate dihydrate
Target species:
  • Cattle
  • Dog
  • Cat
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium acetate
    6.40
    gram(s)
    /
    1000.00
    millilitre(s)
  • Calcium chloride dihydrate
    0.35
    gram(s)
    /
    1000.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    0.31
    gram(s)
    /
    1000.00
    millilitre(s)
  • Potassium chloride
    0.75
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium chloride
    5.00
    gram(s)
    /
    1000.00
    millilitre(s)
  • Sodium citrate dihydrate
    0.75
    gram(s)
    /
    1000.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • S.A.L.F. S.p.A. Laboratorio Farmacologico
Marketing authorisation date:
Manufacturing sites for batch release:
  • S.A.L.F. S.p.A. Laboratorio Farmacologico
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download